Keratoconus is a progressive disorder, usually worsening through the fourth decade of life. The traditional treatment of keratoconus has primarily focused on methods of visual rehabilitation. In the future, controlling the progression of the disease will be another important treatment goal. That would allow more patients to go through life without significant visual impairment. Ultimately, keratoconus will be treated by understanding and controlling the genetic basis of the disease.
Upon completion of this Focal Points module, you should be able to:
- Discuss the indications, surgical techniques, results, and complications of the use of intracorneal ring segments in the treatment of keratoconus.
- Discuss the indications, techniques, results, and complications of collagen crosslinking, with and without photorefractive keratectomy, in the treatment of keratoconus.
- Describe the use of long-acting intracameral gases to treat corneal hydrops.
- Compare the relative merits of deep anterior lamellar keratoplasty and penetrating keratoplasty in the treatment of keratoconus.
Focal Points issues are practical, hands-on discussions of the clinical challenges you face daily. Each issue delivers high-quality, trusted ophthalmic information written and reviewed by leading experts.
Subscribers receive 12 new issues a year, plus access to the Focal Points digital archive.
To access this issue from your laptop or desktop computer, log in to www.aao.org/myonlineproducts with your Academy username and password. To access this issue from your Apple iPad® or Android™ tablet, use the free AAO eBooks app. For more information about the app, visit www.aao.org/ebooks.
The American Academy of Ophthalmology designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Once you have completed this Focal Points issue, please visit CME Central to review or claim your CME.